Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alvotech

8.42
+0.01000.12%
Pre-market: 8.40-0.0200-0.24%05:09 EDT
Volume:708.74K
Turnover:6.07M
Market Cap:2.62B
PE:24.84
High:8.83
Open:8.73
Low:8.42
Close:8.41
Loading ...

Alvotech’s SELARSDI Gains FDA Approval for Interchangeability with Stelara

TIPRANKS
·
05 May

Teva, Alvotech Get FDA Approval for Selarsdi's Interchangeablity With Stelara

MT Newswires Live
·
05 May

Teva and Alvotech Announce FDA Approval of Interchangeability for Selarsdi™ (Ustekinumab-Aekn) With Stelara® (Ustekinumab)

THOMSON REUTERS
·
05 May

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

GlobeNewswire
·
05 May

Teva, Alvotech announce FDA approval of interchangeability for SELARSDI

TIPRANKS
·
05 May

Alvotech Sa - Teva, Alvotech Announce FDA Approval of Interchangeability for Selarsdi (Ustekinumab-Aekn) With Stelara (Ustekinumab)

THOMSON REUTERS
·
05 May

Alvotech Sa - Selarsdi Approved for All Indications Matching Stelara

THOMSON REUTERS
·
05 May

Alvotech Sa - Selarsdi Indicated for Psoriasis, Arthritis, Crohn's, Ulcerative Colitis

THOMSON REUTERS
·
05 May

Teva and Alvotech Announce FDA Approval of Interchangeability for Selarsdi™ (Ustekinumab-Aekn) With Stelara® (Ustekinumab)

THOMSON REUTERS
·
05 May

New Strong Sell Stocks for April 25th

Zacks
·
25 Apr

New Strong Sell Stocks for April 17th

Zacks
·
17 Apr

Nordic Shares Decline; Alvotech Falls Furthest

Dow Jones
·
10 Apr

Alvotech (NASDAQ:ALVO) Just Reported And Analysts Have Been Lifting Their Price Targets

Simply Wall St.
·
30 Mar

Stock Track | Alvotech Plummets 5% as Earnings Per Share Falls Short of Expectations

Stock Track
·
28 Mar

Alvotech Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
28 Mar

Alvotech Achieves Record Revenue Growth in 2024

TIPRANKS
·
28 Mar

Alvotech reports FY24 EPS (87c), one estimate (55c)

TIPRANKS
·
27 Mar

Alvotech sees FY25 revenue $570M-$670M, consensus $629.15M

TIPRANKS
·
27 Mar

Stock Track | Alvotech Plummets 5.80% Pre-Market on Wider-than-Expected 2024 Loss Despite Revenue Growth

Stock Track
·
27 Mar

Exchange-Traded Funds Decline, Equity Futures Mixed Pre-Bell Thursday Ahead of Slew of Economic Data

MT Newswires Live
·
27 Mar